Professor of Medicine/Hepatology
Gastroenterology
Dr. Hie-Won Hann, MD
|
|
Give Review
Dr. Hie-Won Hann works in the field of Gastroenterology. She attended Seoul National University College of Medicine. Hann is a published doctor and has 86 publications published. The lastest was: 'Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation.'
Publications
- Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
- Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case-Control Study.
- Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis b viral therapy.
- Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram.
- Biological aspects of neuroblastomas identified by mass screening in Quebec.
- A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
- Hepatic iron deposition on MR imaging in patients with chronic liver disease: correlation with serial serum ferritin concentration.
- Depression in Korean immigrants with hepatitis B and related liver diseases.
- Lamivudine as initial treatment for chronic hepatitis B in the United States.
- Viral-induced cirrhosis: grading of severity using MR imaging.
- Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging.
- Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation.
- Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial.
- Compensated cirrhosis due to viral hepatitis: using MR imaging to predict clinical progression.
- Liver transplantation for chronic hepatitis B in Asian males.
- Cirrhosis: multiobserver analysis of hepatic MR imaging findings in a heterogeneous population.
- MR imaging of hepatic iron overload in rat.
- Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis.
- Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging.
- Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.
- Changes in clonal expression during the course of acute leukemia: possible subsets in childhood leukemia.
- Lack of influence of T-cell marker and importance of mediastinal mass on the prognosis of acute lymphocytic leukemias of childhood.
- Leukocyte migration inhibition of leukemia-associated antigen in children with acute leukemia and their family members.
- Acute monoblastic leukemia in two infants: clinical histochemical, and immunologic investigations.
- Serum ferritin as a predictor of host response to hepatitis B virus infection.
- Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
- Serum ferritin as a guide to therapy in neuroblastoma.
- Iron and iron binding proteins in persistent generalised lymphadenopathy and AIDS.
- Inhibitory effects of isoferritins from tumour and non-tumour tissues on E-rosette formation.
- Post-steroid panniculitis in acute leukemia.
- Factors affecting survival in patients with cancer of the breast. A preliminary study.
- Favorable remission induction rate with twice weekly doses of L-asparaginase.
- L-asparaginase in the treatment of neoplastic diseases in children.
- Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
- Serum ferritin as a prognostic indicator in neuroblastoma: biological effects of isoferritins.
- Serum selenium assay following serum ferritin assay.
- Prognostic factor in neuroblastoma.
- Source of increased ferritin in neuroblastoma: studies with concanavalin A-sepharose binding.
- Basic and acidic isoferritins in the sera of patients with neuroblastoma.
- Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.
- Prevalence of HBeAg and anti-HBe in chronic active hepatitis, cirrhosis and primary hepatocellular carcinoma in Korea.
- Effects of isoferritins on human granulocytes.
- Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma.
- Prevention of primary hepatocellular carcinoma in Asian populations in the Delaware Valley.
- Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease.
- Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines.
- Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging.
- Chromosome abnormalities in peripheral blood cells of hepatitis B virus chronic carriers.
- Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice.
- Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation.
- Mass-like hepatic hypertrophy: MRI findings with histologic correlation.
- Serum epoxide hydrolase (preneoplastic antigen) in human and experimental liver injury.
- Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice.
- The periodic acid-Schiff reaction and prognosis in children with acute lymphoblastic leukemia.
- Childhood lymphoblastic cancer: subgroups defined by nonhuman primate antisera to human lymphatic leukemia cell antigens.
- Lymphoblasts with T-cell markers in five girls with acute lymphocytic leukemia.
- Studies of T, B, and null lymphocytes during the course of acute lymphocytic leukemia.
- Polycythemia vera in a child with acute lymphocytic leukemia.
- Lymphocyte surface markers and serum immunoglobulins in persons with Down''s syndrome.
- Studies of parents of children with acute leukemia.
- Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatit...
- Active antiviral therapy for chronic hepatitis B and hepatocellular carcinoma.
- Symptomatology and health attitudes of chronic hepatitis B patients in the USA.
- Histological outcome during long-term lamivudine therapy.
- Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.
- The management of chronic hepatitis B in Asian Americans.
- Analysis of GP73 in patients with HCC as a function of anti-cancer treatment.
- Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.
- Recognition and management of HBV infection in a social context.
- Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.
- Question of ALT flare during switch to adefovir from lamivudine: A single center open-label, randomized, safety study (June 17, 2005 to February 5, 2009).
- Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated.
- A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B : Lamivudine resistance.
- Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV).
- Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.
- Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection.
- Baseline HBV DNA level is the most important factor associated with virologic breakthrough in chronic hepatitis B treated with lamivudine.
- Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
- Hepatitis B virus infection in 6,130 unvaccinated Korean-Americans surveyed between 1988 and 1990.
- Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
- A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
- Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B.
- Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
- Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.
- A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
Schools
Seoul National University College of Medicine
Worcester City Hospital
Chldn Hospital Mc Harvard Med School
Doctors Specialties
- Pediatrics
- Gastroenterology
Accepted Insurances
Education
-
Boston Children's Hospital -
Seoul National University College of Medicine
Hospital
-
Thomas Jefferson University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Alvin Htut, MD |
|
|
Dr. Brintha K. Enestvedt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barton D. Scheinfeldt, DO |
|
|
Dr. Stacey R. Zavala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig A. Aronchick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kashish Mehra, MD |
|
|
Dr. Steven L. Mills, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tashveen Kaur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie M. Smith, MD |